Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
317.25
+19.51 (6.55%)
At close: Jan 16, 2026, 4:00 PM EST
313.00
-4.25 (-1.34%)
After-hours: Jan 16, 2026, 7:40 PM EST
PRAX Market Cap
PRAX has a market cap or net worth of $8.8 billion as of January 16, 2026. Its market cap has increased by 494.05% in one year.
Market Cap
8.80B
Enterprise Value
8.41B
1-Year Change
494.05%
Ranking
Category
Stock Price
$317.25
Market Cap Chart
Since the IPO on October 16, 2020, PRAX's market cap has increased from $698.02M to $8.80B, an increase of 1,160.73%. That is a compound annual growth rate of 61.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 8.80B | 19.40% |
| Dec 31, 2025 | 7.37B | 397.55% |
| Dec 31, 2024 | 1.48B | 675.84% |
| Dec 29, 2023 | 190.94M | 70.27% |
| Dec 30, 2022 | 112.14M | -87.31% |
| Dec 31, 2021 | 883.49M | -58.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |